Sign In

Derek Mazur

Director, Portfolio Management at Paragon Biosciences

Professional Background

Derek Mazur is a distinguished professional known for his extensive expertise in biotechnology, venture capital, and business development. Currently serving as a Director at Paragon Biosciences, Derek has dedicated his career to fostering innovative enterprises that aim to redefine industries such as gene therapy, synthetic biology, and artificial intelligence. Under his leadership, Paragon Biosciences has successfully acquired, incubated, invested in, and operated cutting-edge life science companies, proving its commitment to improving human health and wellness. The firm’s accomplishments are bolstered by a seasoned management team that has collaborated for over two decades, ensuring a well-rounded approach to advancing biopharmaceutical and technological solutions.

Paragon’s impressive track record includes significant investments, with over $1 billion directed towards various portfolio companies. The firm has an ambitious goal of deploying an additional $500 million each year, solidifying its position as a key player in the life sciences venture capital landscape. Derek's role in guiding strategic decisions and portfolio management is pivotal to Paragon's mission, which focuses on generating viable solutions to enhance the human condition while simultaneously achieving robust economic returns.

Before his impactful role at Paragon, Derek gained invaluable experience at Santé Ventures—a top-quartile venture capital fund specializing in life sciences and machine learning, with an impressive $1 billion in assets under management. During his tenure at Santé, he stepped through various positions from Senior Analyst to Senior Associate, where he honed his skills in evaluating and backing burgeoning healthcare innovations.

In addition to his investment roles, Derek has a strong foundation in healthcare investment banking. His early career included positions as an Investment Banking Analyst at prestigious firms such as Houlihan Lokey and SunTrust Robinson Humphrey, where he was involved in critical financial analyses and strategic advisory assignments that provided him with essential insights into the dynamics of healthcare financing.

Education and Achievements

Derek’s academic credentials are firmly rooted in the sciences and business. He earned his Master of Science degree in Biotechnology from The Johns Hopkins University, a world-renowned institution known for its rigorous scientific programs and pioneering research. This academic background provides Derek with a solid understanding of the intricate biological principles that drive many of his investment decisions in the biotechnology sector.

Prior to this, he earned a Bachelor of Business Administration in Finance from Emory University. This degree equipped him with essential financial principles and a business acumen that serve him well in the venture capital world—particularly in assessing the financial viability and potential growth of life science ventures.

Derek’s education began at Lake Forest Academy, where he developed a passion for exploring the natural world and learned to appreciate the little things in life, a theme that has shaped his professional journey.

Notable Positions and Contributions

Derek has held various influential positions throughout his career. At Paragon Biosciences, as the Director of Portfolio Management, he has been instrumental in shaping the firm’s investment strategies and overseeing the growth and development of portfolio companies. His previous role at Santé Ventures saw him rising through the ranks, where he was celebrated for his analytical skills and the ability to identify high-potential investment opportunities in the life sciences field.

Moreover, Derek has contributed to the success of several healthcare initiatives outside his primary role at Paragon. He served on the Oversight Committee at Biolocity, guiding innovative projects that aim to accelerate technology commercialization within the life sciences. Furthermore, his insights were valuable during his time as a Board Observer at multiple organizations, including Remedy and Iterion Therapeutics, where he provided crucial advice and direction to early-stage companies on their path to success.

As a healthcare investment banker, Derek worked with top firms, harnessing his financial expertise to support impactful ventures. His experience at Houlihan Lokey and SunTrust Robinson Humphrey provided a robust foundation in strategic financial advisory, position him as a knowledgeable asset in any investment discussion. This rich tapestry of experiences has positioned Derek as a thought leader and go-to expert in the fields of venture capital and healthcare innovation.

Beyond his professional endeavors, Derek is an ardent advocate for collaboration and networking within the industry. He actively encourages conversations with genuine and insightful individuals who are passionate about making a difference in the life sciences realm.

In conclusion, Derek Mazur continues to influence the intersection of healthcare and technology through his understanding of both the scientific and business facets of the industry. His commitment to fostering innovation while improving the human condition serves as an exemplar for aspiring professionals in the biotechnology and venture capital sectors.

Related Questions

How did Derek Mazur transition from a background in biology to a prominent role in venture capital?
What strategies has Derek Mazur implemented to ensure success at Paragon Biosciences?
In what ways has Derek Mazur contributed to the growth and development of portfolio companies?
What insights can Derek Mazur share about the future of artificial intelligence in healthcare?
How has Derek Mazur's education at Johns Hopkins University and Emory University influenced his career path?
Derek Mazur
Add to my network

Location

Chicago, Illinois, United States